Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 5-year average of -2099.04%, near the high end of its 5-year range (-18819.54%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
-3033.65%
OPERATING MARGIN AVG 5Y
-2099.04%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 845 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Praxis Precision Medicines, Inc.
Market Cap
$7.69B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-3033.65%
5Y Avg
-2099.04%
Market Cap
$7.61B
Operating Margin
-695.44%
TTM Avg
-1799.08%
3Y Avg
-2632.66%
5Y Avg
-1827.24%
Market Cap
$7.61B
Operating Margin
25.61%
TTM Avg
21.87%
3Y Avg
15.23%
5Y Avg
12.87%
Market Cap
$7.58B
Operating Margin
-92.94%
TTM Avg
-50.55%
3Y Avg
-48.57%
5Y Avg
-48.57%
Market Cap
$7.93B
Operating Margin
5.56%
TTM Avg
-28.40%
3Y Avg
-70.84%
5Y Avg
-47.21%
Market Cap
$7.95B
Operating Margin
17.05%
TTM Avg
16.38%
3Y Avg
-1949.35%
5Y Avg
-32157.96%
Market Cap
$7.32B
Operating Margin
-40.47%
TTM Avg
-53.92%
3Y Avg
-55.65%
5Y Avg
-41.65%
Market Cap
$8.37B
Operating Margin
4.07%
TTM Avg
-1.39%
3Y Avg
-5.39%
5Y Avg
-20.02%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. (PRAX) | $7.69B | 0.00% | 0.00% | -3033.65% | -2099.04% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.61B | -695.44% | -1799.08% | -2632.66% | -1827.24% |
| HealthEquity, Inc. (HQY)vs › | $7.61B | 25.61% | 21.87% | 15.23% | 12.87% |
| Hinge Health, Inc. (HNGE)vs › | $7.58B | -92.94% | -50.55% | -48.57% | -48.57% |
| Caris Life Sciences, Inc. (CAI)vs › | $7.93B | 5.56% | -28.40% | -70.84% | -47.21% |
| TG Therapeutics, Inc. (TGTX)vs › | $7.95B | 17.05% | 16.38% | -1949.35% | -32157.96% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.32B | -40.47% | -53.92% | -55.65% | -41.65% |
| Alkermes plc (ALKS)vs › | $7.00B | 17.21% | 22.11% | 17.14% | 11.01% |
| Oscar Health, Inc. (OSCR)vs › | $8.37B | 4.07% | -1.39% | -5.39% | -20.02% |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.59B | -891.33% | -723.58% | -500.53% | -379.37% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -856.97% |
| 2024-09-30 | -18819.54% |
| 2024-06-30 | -10500.84% |
| 2024-03-31 | -9718.33% |
| 2023-12-31 | -5399.22% |
| 2023-09-30 | -5452.14% |
| 2023-06-30 | -4476.31% |
| 2023-03-31 | -5577.01% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
